Serán News and Resources

Serán BioScience, a contract development and manufacturing organization (CDMO), has announced a strategic growth transaction of more than $200 million. The investment, led by Bain Capital Life Sciences, aims to support the company’s continued expansion, with existing investor Vivo Capital